Senior Director, Safety and Clinical Innovation
GlaxoSmithKline
Research Triangle Park, United States
Greg Powell is the Senior Director of Safety and Clinical Innovation at GlaxoSmithKline. He has a PharmD from the University of Florida, an MBA from East Carolina University as well as a BS of Pharmacy from the University of North Carolina where he has precepted PharmD students for the last 10+ years. He has 22 years of pharmacovigilance experience at GSK, with his time split between driving innovation in pharmacovigilance and the practical application across a range of safety related activities. His areas of innovation experience include: PK/PD/chemical descriptors, clinical trials data, spontaneous reports, RWD, social media, and crowdsourcing for medical insight, and has published numerous manuscripts/abstracts in these areas.
Disclosure information not submitted.
Pharmacovigilance and Signal Detection
Thursday, August 24, 2023
2:00 PM – 6:00 PM ADT